Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Nov 14, 2023. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 154
- −2 vs. Q2 2023
- Portfolio value
- $6.21B
- −$803.5M (−11.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZBHZimmer Biomet Holdings, Inc. | Stock | 284,888 | $32.0M | 0.5% | +530.0% | Added | History |
| ATRCAtriCure, Inc. | COM | 747,560 | $32.7M | 0.5% | −1,053−0.1% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 66,468 | $33.6M | 0.5% | −29,633−30.8% | Reduced | History |
| DHRDanaher Corp | Stock | 136,533 | $33.9M | 0.5% | −47,176−25.7% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 266,226 | $34.5M | 0.6% | −22,553−7.8% | Reduced | History |
| CICigna Group | Stock | 125,502 | $35.9M | 0.6% | +75,103+149.0% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 155,643 | $38.3M | 0.6% | −4,872−3.0% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 898,400 | $40.8M | 0.7% | −900−0.1% | Reduced | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,885,000 | $41.1M | 0.7% | +714,200+17.1% | Added | History |
| ARVNArvinas, Inc. | COM | 2,125,200 | $41.7M | 0.7% | −1,800−0.1% | Reduced | History |
| PODDInsulet Corp | Stock | 264,359 | $42.2M | 0.7% | −59,235−18.3% | Reduced | History |
| LLYEli Lilly & Co | Stock | 81,541 | $43.8M | 0.7% | −13,614−14.3% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 631,487 | $44.1M | 0.7% | +57,124+9.9% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 2,142,769 | $44.5M | 0.7% | +49,835+2.4% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 229,342 | $44.9M | 0.7% | −85,171−27.1% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 224,100 | $45.6M | 0.7% | −46,946−17.3% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,803,313 | $45.7M | 0.7% | +193,400+2.0% | Added | History |
| ACCDAccolade, Inc. | COM | 4,527,923 | $47.9M | 0.8% | +6,864+0.2% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 134,330 | $48.2M | 0.8% | −203−0.2% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 114,441 | $50.0M | 0.8% | 00.0% | Unchanged | History |
| MDTMedtronic plc | Stock | 641,492 | $50.3M | 0.8% | −769,000−54.5% | Reduced | History |
| SWAVShockwave Medical, Inc. | COM | 254,279 | $50.6M | 0.8% | −16,247−6.0% | Reduced | History |
| ALGNAlign Technology Inc | COM | 166,886 | $51.0M | 0.8% | −4,254−2.5% | Reduced | History |
| EXELExelixis, Inc. | COM | 2,375,925 | $51.9M | 0.8% | −158,075−6.2% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 158,438 | $52.0M | 0.8% | −5,900−3.6% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,900,000 | $52.3M | 0.8% | +100,000+5.6% | Added | History |
| PENPenumbra Inc | COM | 237,252 | $57.4M | 0.9% | +3,032+1.3% | Added | History |
| PACBPacific Biosciences of California, Inc. | COM | 7,245,188 | $60.5M | 1.0% | −297,641−3.9% | Reduced | History |
| DXCMDexcom Inc | COM | 685,733 | $64.0M | 1.0% | −75,983−10.0% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 1,025,457 | $71.0M | 1.1% | −12,635−1.2% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 3,513,351 | $72.3M | 1.2% | +398,976+12.8% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,284,293 | $73.9M | 1.2% | −3,330−0.1% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 173,887 | $75.7M | 1.2% | +71,434+69.7% | Added | History |
| EXASExact Sciences Corp | COM | 1,119,819 | $76.4M | 1.2% | +113,047+11.2% | Added | History |
| BDXBecton Dickinson & Co | Stock | 304,230 | $78.7M | 1.3% | −33,493−9.9% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,162,735 | $79.9M | 1.3% | −138,176−4.2% | Reduced | History |
| HUMHumana Inc | Stock | 170,046 | $82.7M | 1.3% | +42,673+33.5% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,013,500 | $99.3M | 1.6% | 00.0% | Unchanged | History |
| EVHEvolent Health, Inc. | CL A | 3,677,115 | $100.1M | 1.6% | +228,793+6.6% | Added | History |
| AXNXAxonics, Inc. | COM | 2,252,851 | $126.4M | 2.0% | +29,433+1.3% | Added | History |
| SYKStryker Corp | Stock | 475,613 | $130.0M | 2.1% | −1,333−0.3% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 258,205 | $130.2M | 2.1% | +48,078+22.9% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 4,721,500 | $130.7M | 2.1% | −24,500−0.5% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 2,646,295 | $139.7M | 2.3% | −15,157−0.6% | Reduced | History |
| INCYIncyte Corp | COM | 2,491,450 | $143.9M | 2.3% | −149,315−5.7% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,560,968 | $151.2M | 2.4% | −85,533−5.2% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,495,325 | $154.5M | 2.5% | −29,734−1.9% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 894,345 | $158.4M | 2.6% | −5,305−0.6% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,170,250 | $165.1M | 2.7% | −31,550−1.0% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 828,999 | $242.3M | 3.9% | −13,225−1.6% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,583,550 | $290.6M | 4.7% | −29,250−1.1% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,002,735 | $348.7M | 5.6% | −94,431−8.6% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,233,700 | $418.8M | 6.7% | −146,600−1.6% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 911,530 | $448.1M | 7.2% | −11,754−1.3% | Reduced | History |
Sold out since Q2 2023 (12)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| BAXBaxter International Inc | Stock | 213,434 | $9.72M | 0.1% | History |
| SGHTSight Sciences, Inc. | COM | 286,284 | $2.37M | <0.1% | History |
| AMWLAmerican Well Corp | CL A | 953,613 | $2.00M | <0.1% | History |
| DNLIDenali Therapeutics Inc. | COM | 44,050 | $1.30M | <0.1% | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 55,600 | $1.10M | <0.1% | History |
| DICEDICE Therapeutics, Inc. | COM | 18,200 | $845.6K | <0.1% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 45,000 | $813.1K | <0.1% | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 20,700 | $738.2K | <0.1% | History |
| VKTXViking Therapeutics, Inc. | COM | 33,000 | $534.9K | <0.1% | History |
| Abcam PLC000380204 | ADS | 2,573 | $63.0K | <0.1% | – |
| JMIAJumia Technologies AG | SPONSORED ADS | 18,000 | $61.6K | <0.1% | History |
| KZRKezar Life Sciences, Inc. | COM | 10,000 | $24.5K | <0.1% | History |